This wiki has undergone a migration to Confluence found Here
Difference between revisions of "May 2017 Pharmacy WGM Agenda"
Jump to navigation
Jump to search
(10 intermediate revisions by 2 users not shown) | |||
Line 68: | Line 68: | ||
* Finalize Agenda | * Finalize Agenda | ||
* Reps to other WGs | * Reps to other WGs | ||
− | ** Tuesday Q2 - OO - 1 rep | + | ** Tuesday Q2 - OO - 1 rep - will include a Catalogue Services update - Jose will attend |
− | ** Tuesday Q3 - SD - CDA Product Family - 1 rep | + | ** Tuesday Q3 - SD - CDA Product Family - 1 rep - Tom will attend |
− | ** Wednesday Q4 Patient Care - allergy/intolerance - 1 rep | + | ** Wednesday Q2 - CDS - 1 rep - update on Chemotherapy Guide - John will attend |
− | ** Thursday Q1 Patient Care- Care Plan - 1 rep | + | ** Wednesday Q4 Patient Care - allergy/intolerance - 1 rep - reach out and ask if they need our input |
+ | ** Thursday Q1 Patient Care- Care Plan - 1 rep - John to attend | ||
* Assign Roles for Quarters | * Assign Roles for Quarters | ||
* If we have new attendees, review | * If we have new attendees, review | ||
Line 77: | Line 78: | ||
** Overview of Template work | ** Overview of Template work | ||
* Hot Topics | * Hot Topics | ||
− | * [http://www.hl7.org/documentcenter/public/wg/medication/minutes/HL7_Pharmacy_WG_Meeting_Minutes_-_San%20Antonio%202017_Draft.docx Approval of | + | * [http://www.hl7.org/documentcenter/public/wg/medication/minutes/HL7_Pharmacy_WG_Meeting_Minutes_-_San%20Antonio%202017_Draft.docx Approval of January 2017 WGM Minutes ] |
− | ||Melva|| | + | ||Melva||John||Comillas |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3 - 2:45 - 4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q3 - 2:45 - 4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
− | * Prep for | + | * Prep for Joint FHIR meeting |
− | * | + | **QA rules & Workflow patterns that will be used for R4 |
− | ||Melva|| | + | ***Feedback on existing rules and patterns by end of May 2017 (issues with existing ones, proposals for change) |
+ | ***Candidate set of rules for R4 (including tooling support) will be published by FMG by end of June 2017 | ||
+ | ***FMG will accept feedback in early July (1st two weeks) and will publish final rules and tool updates by end of July | ||
+ | ***Work groups should plan to align with these patterns and by Nov. publication submission deadline for existing and proposed STU content | ||
+ | ***Encourage you to start sooner rather than later, so if changes are needed, there's a chance to apply them. (We'll be reluctant to make any changes late in the process.) | ||
+ | **Planned ballot timeline: | ||
+ | ***Dec 2017 (Jan ballot) - "for comment" | ||
+ | ***Apr 2018 (May ballot) - STU + Normative | ||
+ | ***Nov 2018 - ready to publish | ||
+ | **For this week: | ||
+ | ***1. What (if anything) does your WG want to be a candidate for normative in the next release? | ||
+ | ****Let your FMG member know by Thur Q3 if you want your candidates identified in product director's blog post to community | ||
+ | ****Need agreement by both work group and FMG | ||
+ | ***2. What new resources/profiles/IGs would you like to be candidates for STU in the next release? | ||
+ | ****Draft content for Nov. 2017 ballot deadline (if you don't have 'reasonable' content in the "for comment" ballot, you can't be STU in May) | ||
+ | ****Resource/profile proposals approved by FMG no later than end of Jan. (so get them in around Nov. 2017) | ||
+ | ***3. Maturity levels for other resources/profiles/pages: | ||
+ | ****What are your targets for R4? | ||
+ | ****How will you get there? | ||
+ | ***4. Any concerns/issues? | ||
+ | ****QA, resource availability, tools, other? | ||
+ | ||Melva||John||Comillas | ||
|- | |- | ||
||Q4 - 4:30-6pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4 - 4:30-6pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
+ | * Pharmacy Co-Chair elections | ||
* Update on Podiatry Functional Profile Project (Michael Brody) | * Update on Podiatry Functional Profile Project (Michael Brody) | ||
+ | * Swedish Project overview | ||
+ | * Prep for Clinicians on FHIR | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | || | + | ||John||Melva||Comillas |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
Line 100: | Line 125: | ||
||Q1 - 10-11:30am||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q1 - 10-11:30am||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* NL Project Update and Discussion (Michael Tan) | * NL Project Update and Discussion (Michael Tan) | ||
− | || | + | ||John||Melva||Comillas |
|- | |- | ||
||Q2 - 12-1:30pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2 - 12-1:30pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
Line 106: | Line 131: | ||
* Joint with FHIR Infrastructure | * Joint with FHIR Infrastructure | ||
* Topics TBD | * Topics TBD | ||
− | || | + | ||Melva||John||Marsellas |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3 - 2:45-4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q3 - 2:45-4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | || | + | ||John (Melva not available)||Jenni||Comillas |
|- | |- | ||
||Q4 - 430-6pm||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||Q4 - 430-6pm||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||
Line 132: | Line 157: | ||
** 3 year plan review | ** 3 year plan review | ||
** Action Item list review | ** Action Item list review | ||
− | || | + | ||John||Melva||Comillas |
|- | |- | ||
||Q2 - 12-1:30pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2 - 12-1:30pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy Template Work (Kai) | * Pharmacy Template Work (Kai) | ||
− | ||Melva|| | + | ||Melva||Melva||Comillas |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3 - 2:45 - 4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3 - 2:45 - 4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
− | * | + | * FHIR Tracker Items |
− | + | ||Melva||John||TBD | |
− | ||Melva|| | ||
|- | |- | ||
||Q4 - 4:30-6pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4 - 4:30-6pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Rep to Patient Care | * Rep to Patient Care | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | || | + | ||John||Melva||TBD |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| | ||
Line 156: | Line 180: | ||
|rowspan="2" align="middle" |AM | |rowspan="2" align="middle" |AM | ||
||Q1 - 10-1130am||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q1 - 10-1130am||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
− | * Rep to Patient Care | + | * Rep to Patient Care |
+ | * Norwegian Project Update - MedicationStatement Profile | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | ||Melva|| | + | ||Melva||Melva||TBD |
|- | |- | ||
||Q2 - 12-1:30pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2 - 12-1:30pm||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
+ | *Overview of IDMP (Jean) | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | || | + | ||John||Melva||TBD |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3 - 2:45-4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3 - 2:45-4pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | || | + | ||John (Melva not available)||Jenni||TBD |
|- | |- | ||
||Q4 - 4:30-6pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4 - 4:30-6pm||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* CIMI Medication Model | * CIMI Medication Model | ||
− | || | + | ||John (Melva not available)||Jenni||TBD |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| |
Latest revision as of 09:05, 9 May 2017
Contents |
Related Links |
Meeting Schedule
- Saturday-Thursday:
- Q1 = 10:00 am – 11:30 pm
- Q2 = 12:00 pm – 1:30 pm
- Q3 = 2:45 pm – 4:00 pm
- Q4 = 4:30 pm – 6:00 pm
- Friday:
- Q1 = 9:00 – 10:30 am
- Q2 = 11:00 – 12:30 pm
- Q3 = 1:45 – 3:00 pm
Agenda
Scott not available - not in Madrid
Day | Date | ' | Time | Icon | Event | Chair | Scribe | Room |
Sunday | May 7, 2017 | AM | Q1 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA |
Q2 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA | |||
PM | Q3 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA | ||
Q4 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA | |||
. | ||||||||
Monday | May 8, 2017 | AM | Q1 - 10-11:30am | ![]() |
Pharmacy WG Not Meeting - Plenary | NA | NA | NA |
Q2 - 12 - 1:30pm | ![]() |
Committee Meeting
|
Melva | John | Comillas | |||
PM | Q3 - 2:45 - 4pm | ![]() |
Committee Meeting
|
Melva | John | Comillas | ||
Q4 - 4:30-6pm | ![]() |
Committee Meeting
|
John | Melva | Comillas | |||
. | ||||||||
Tuesday | May 9, 2017 | AM | Q1 - 10-11:30am | ![]() |
Committee Meeting
|
John | Melva | Comillas |
Q2 - 12-1:30pm | ![]() |
Committee Meeting
|
Melva | John | Marsellas | |||
PM | Q3 - 2:45-4pm | ![]() |
Committee Meeting
|
John (Melva not available) | Jenni | Comillas | ||
Q4 - 430-6pm | ![]() |
Joint with PHER (PHER hosting)
|
NA | NA | TBD | |||
. | ||||||||
Wednesday | May 10, 2017 | AM | Q1 - 10-1130am | ![]() |
Committee Meeting
|
John | Melva | Comillas |
Q2 - 12-1:30pm | ![]() |
Committee Meeting
|
Melva | Melva | Comillas | |||
PM | Q3 - 2:45 - 4pm | ![]() |
Committee Meeting
|
Melva | John | TBD | ||
Q4 - 4:30-6pm | ![]() |
Committee Meeting
|
John | Melva | TBD | |||
. | ||||||||
Thursday | May 11, 2017 | AM | Q1 - 10-1130am | ![]() |
Committee Meeting
|
Melva | Melva | TBD |
Q2 - 12-1:30pm | ![]() |
Committee Meeting
|
John | Melva | TBD | |||
PM | Q3 - 2:45-4pm | ![]() |
Committee Meeting
|
John (Melva not available) | Jenni | TBD | ||
Q4 - 4:30-6pm | ![]() |
Committee Meeting
|
John (Melva not available) | Jenni | TBD | |||
. | ||||||||
Friday | May 12, 2017 | AM | Q1 | ![]() |
Pharmacy WG Not Meeting |
NA | NA | NA |
Q2 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA | |||
PM | Q3 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA | ||
Q4 | ![]() |
Pharmacy WG Not Meeting | NA | NA | NA | |||
. |
Icons: